Episode Details
Back to EpisodesB+L Receives FDA Approval for enVista Envy IOL
Published 1 year, 7 months ago
Description
Bausch + Lomb receives FDA approval for a new IOL on its enVista platform; Nanoscope advances it gene therapy for retinitis pigmentosa; and Orasis completes a major funding round to support the launch of its presbyopia eye drop.
Learn more about your ad choices. Visit megaphone.fm/adchoices